Researcher.Life Logo

Drug Development and Registration : Impact Factor & More

eISSN: 2658-5049pISSN: 2305-2066
JournalOpen Access

Key Metrics

CiteScore
0.6
SNIP
0.81
Recommended pre-submission checks
Powered by Paperpal by Editage

Drug Development and Registration Journal Specifications

Overview
Publisher Center of Pharmaceutical Analytics
Language Russian
Publication Time8
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageRussian
Society/Institute/SponsorI.M. Sechenov First Moscow State Medical University (Sechenov University)
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 8
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in Drug Development and Registration ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Development and Registration

Development of the formulation and manufacturing process of lozenges with Ajania fruticulosa (Ledeb.) Poljak dry extract using the Quality by Design concept
  • 30 Jan 2026
  • Drug development & registration
Development, validation, and application of a method for assessing the viability of Escherichia coli for flow cytometry
  • 30 Jan 2026
  • Drug development & registration
Comparative Hepatoprotective Effects of Dapagliflozin to Silymarin Against Cyclophosphamide-Induced Liver Injury in Rats: Biochemical, Antioxidants and Histopathological Studies
  • 23 Jan 2026
  • Drug development & registration
Simulation of pharmacokinetic parameters of thiozonide in patients with low body weight based on a population pharmacokinetic model
  • 26 Dec 2025
  • Drug development & registration
Acute toxicity and pharmacokinetic parameters of 2-aminopyrrole with antitumour activity
  • 26 Dec 2025
  • Drug development & registration
Development of medicines based on 5-phenyltetrazole derivatives for the pharmacological correction of metabolic phenomena
  • 26 Dec 2025
  • Drug development & registration
Development of the formulation and manufacturing process of lozenges with Ajania fruticulosa (Ledeb.) Poljak dry extract using the Quality by Design concept
  • 30 Jan 2026
  • Drug development & registration
Development, validation, and application of a method for assessing the viability of Escherichia coli for flow cytometry
  • 30 Jan 2026
  • Drug development & registration
Comparative Hepatoprotective Effects of Dapagliflozin to Silymarin Against Cyclophosphamide-Induced Liver Injury in Rats: Biochemical, Antioxidants and Histopathological Studies
  • 23 Jan 2026
  • Drug development & registration
Simulation of pharmacokinetic parameters of thiozonide in patients with low body weight based on a population pharmacokinetic model
  • 26 Dec 2025
  • Drug development & registration
Acute toxicity and pharmacokinetic parameters of 2-aminopyrrole with antitumour activity
  • 26 Dec 2025
  • Drug development & registration
Development of medicines based on 5-phenyltetrazole derivatives for the pharmacological correction of metabolic phenomena
  • 26 Dec 2025
  • Drug development & registration

FAQs on Drug Development and Registration